Navigation Links
Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles 'Snuffy' Myers Announces Vitamin D Clinical Trials
Date:4/16/2008

hapter. "But we're eager to hear about the new trials Dr. Myers is working on."

For information on the event or directions please call Richard Gillespie at 703-497-0628.

About FCRE

The Foundation for Cancer Research and Education (FCRE) is dedicated to cutting edge research and clinically driven educational programs. A streamlined organization with specific research goals, FCRE's mission is to prolong patients' lives with focused research strategies. For more information or for a list of FCRE's outreach programs call 800-305-2432 or go to http://www.cancer-foundation.org.


'/>"/>
SOURCE Foundation for Cancer Research and Education
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)... First-Ever PEGylation of a Small Molecule with ... SAN CARLOS, Calif., May 16 /PRNewswire-FirstCall...d initial results today from a Phase 1,study of NK...ificant,anti-tumor activity in patients with refra...at Nektar,s small molecule PEGylation technology,p...
(Date:5/15/2008)...icacy for Population Most Affected by Disease -, ...wire-FirstCall/ --,Bayer HealthCare Pharmaceutical...NXX ) today announced that Nexavar(R) (sorafenib) ... 47.3 percent (HR=0.68;,p-value=0.014) in patients...llular carcinoma (HCC), or primary liver cancer ve...
(Date:5/15/2008)...cal Data from Prostate, Colorectal and Ovarian ...o Hold Investor Event on Sun., June 1 with Oncolog.../- Poniard,Pharmaceuticals,...y focused,on oncology, today announced that the Co... of picoplatin, in various tumor types and combina...
(Date:5/15/2008)...monstrated in Blacks, Hispanics/Latinos, People ..., PARSIPPANY, N.J., May 15 /- Daiich...d at the American Society of,Hypertension,s Twenty...w,Orleans demonstrated that the powerful combinati...mil) safely and effectively helped,patients across...
Breaking Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7John D Baxter M D Joins Bionovos Board of Directors 17072 1John D Baxter M D Joins Bionovos Board of Directors 17072 2John D Baxter M D Joins Bionovos Board of Directors 17072 3Eisai Corporation of North America Announces Appointment of Vice President of U S Corporate Communications 17069 1Eisai Corporation of North America Announces Appointment of Vice President of U S Corporate Communications 17069 2BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery 26 Development of Innovative Therapeutics World Congress 4674 1BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery 26 Development of Innovative Therapeutics World Congress 4674 2BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery 26 Development of Innovative Therapeutics World Congress 4674 3Boston Scientific Receives Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4671 1Boston Scientific Receives Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4671 2Boston Scientific Receives Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4671 3
(Date:5/16/2008)...inhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corpor...eting and,distribution pharmaceutical companies, t...e following conferences:, (1) The Roth Annual C... David Gao, Chief Executive Officer of the Co...ay 19, 2008, at 4:40 pm local time at the Reg...
(Date:5/16/2008)...rs at The University of Texas M. D. Anderson Cance...ills leukemia cells by shutting down their energy ...clinical study, Lauren Akers, D.O., postdoctoral f... Anderson, found that combining a novel glycolysis..., induced more than 90 percent cell death in human...
(Date:5/16/2008)...ice Announcement Available, RADNOR, Pa., May 16 /...nal Mental Health Month and Older Pennsylvanians M...) will offer an important message to senior,citize...ic service,announcement developed by Feeling Blue ...ealth problem of depression and to offer hope to o...
(Date:5/16/2008)...ire/ -- Tao Formulations announces the,official la... the Internal,Medicine 2008 conference in Washingt...on of years of research to develop a safe, all-nat... relieving menopausal symptoms., Company founder ...cian,and gynecologist, founded Tao Formulations (...
Breaking Medicine News(10 mins):Health News:BMP Sunstone Announces Participation in May Investor Conferences 2Health News:New drug combination brings 1-2 punch against acute leukemia 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula 2
... that a new extended-release formulation of metfor... diabetes as opposed// to the traditional twice a ...new drug, which is marketed under the brand name G...'s tolerance for higher doses of the drug, accordi...
...ted that patients who are at a high risk for devel...g a combination of vitamins E and C// plus ibuprof...in people who have a mutated gene for apolipoprote...on predisposing them to Alzheimer's disease. Re...
...ani Ramadoss made a reassuring announcement that w...HIV//. With the help of 48 additional centers to b...et of providing free anti-AIDS drugs to one lakh p...e a renewed thrust to India’s efforts in combating...
...rch conducted by the scientists at the University ...present in the air may have an adverse// effect on...found in the pollution from traffic exhaust, house..., cosmetics and clothes. Nanoparticles are atoms ...
Other Medicine News:
For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model.
Threaded ends permit guarding the needle and gouge within the handle. Set consists of one each : E0828 A needle tip, E0828 B gauge tip and E0828 C handle. Most popular size or model.
Battery operated single speed motorized handpiece, tip cover, supplied with 0.5 mm tungsten burr (E0815 0.5) and one battery size "AA".
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle.
Medicine Products: